Total Payments
$1,155
2024 Payments
$309.42
Companies
8
Transactions
32
Medicare Patients
787
Medicare Billing
$98,374
Payment Breakdown by Category
Food & Beverage$1,005 (87.0%)
Consulting$100.00 (8.7%)
Education$50.00 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,005 | 29 | 87.0% |
| Consulting Fee | $100.00 | 1 | 8.7% |
| Education | $50.00 | 2 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $632.46 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $144.38 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $113.01 | 5 | $0 (2019) |
| COMSORT, Inc | $100.00 | 1 | $0 (2018) |
| Embecta Corp. | $62.70 | 1 | $0 (2023) |
| Smith & Nephew, Inc. | $50.00 | 2 | $0 (2017) |
| AbbVie Inc. | $27.39 | 1 | $0 (2021) |
| Cumberland Pharmaceuticals, Inc. | $24.56 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $309.42 | 9 | ViiV Healthcare Company ($284.86) |
| 2023 | $241.49 | 6 | ViiV Healthcare Company ($178.79) |
| 2022 | $228.04 | 5 | Merck Sharp & Dohme LLC ($144.38) |
| 2021 | $90.37 | 3 | ViiV Healthcare Company ($62.98) |
| 2020 | $22.17 | 1 | ViiV Healthcare Company ($22.17) |
| 2019 | $36.76 | 2 | Gilead Sciences, Inc. ($36.76) |
| 2018 | $176.25 | 4 | COMSORT, Inc ($100.00) |
| 2017 | $50.00 | 2 | Smith & Nephew, Inc. ($50.00) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $22.29 | General |
| 09/19/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: HIV | ||||||
| 09/13/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: HIV | ||||||
| 09/05/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: HIV | ||||||
| 04/10/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $117.42 | General |
| 04/09/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: HIV | ||||||
| 02/27/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: HIV | ||||||
| 02/08/2024 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 01/03/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: HIV | ||||||
| 10/07/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: HIV | ||||||
| 09/17/2023 | Embecta Corp. | BD Nano 2nd Gen Pen Needle (Device) | Food and Beverage | In-kind items and services | $62.70 | General |
| Category: Diabetes Care | ||||||
| 04/07/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: HIV | ||||||
| 03/29/2023 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $107.09 | General |
| 02/25/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: HIV | ||||||
| 02/01/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: HIV | ||||||
| 10/18/2022 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Food and Beverage | In-kind items and services | $144.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/12/2022 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: HIV | ||||||
| 06/04/2022 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: HIV | ||||||
| 04/02/2022 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: HIV | ||||||
| 02/24/2022 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: HIV | ||||||
| 05/20/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: HIV | ||||||
| 04/09/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/04/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $34.63 | General |
| Category: HIV | ||||||
| 09/23/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: HIV | ||||||
| 08/28/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 194 | 279 | $72,320 | $22,590 |
| 2022 | 7 | 254 | 360 | $98,996 | $32,265 |
| 2021 | 6 | 224 | 304 | $91,020 | $30,444 |
| 2020 | 3 | 115 | 159 | $40,231 | $13,075 |
Total Patients
787
Total Services
1,102
Medicare Billing
$98,374
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 124 | 203 | $45,821 | $14,243 | 31.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 58 | 64 | $23,744 | $7,481 | 31.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $2,755 | $866.52 | 31.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 106 | 176 | $35,906 | $11,745 | 32.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 60 | $23,400 | $7,658 | 32.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 56 | $16,422 | $5,588 | 34.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $10,224 | $3,487 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 22 | $6,204 | $1,573 | 25.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $3,528 | $1,130 | 32.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 16 | 16 | $3,312 | $1,083 | 32.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 78 | 111 | $32,769 | $11,222 | 34.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 32 | 33 | $18,927 | $6,580 | 34.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 66 | 98 | $20,190 | $6,579 | 32.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 24 | 25 | $9,775 | $3,184 | 32.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 24 | $6,668 | $1,968 | 29.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 13 | 13 | $2,691 | $911.65 | 33.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 66 | 104 | $21,518 | $6,916 | 32.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 26 | 32 | $9,568 | $3,208 | 33.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 23 | 23 | $9,145 | $2,950 | 32.3% |
About Dr. Vel Sivapalan, MD
Dr. Vel Sivapalan, MD is a Emergency Medicine healthcare provider based in Chatham, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427005255.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vel Sivapalan, MD has received a total of $1,155 in payments from pharmaceutical and medical device companies, with $309.42 received in 2024. These payments were reported across 32 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,005).
As a Medicare-enrolled provider, Sivapalan has provided services to 787 Medicare beneficiaries, totaling 1,102 services with total Medicare billing of $98,374. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Infectious Disease, Internal Medicine
- Location Chatham, NJ
- Active Since 05/27/2006
- Last Updated 03/30/2015
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1427005255
Products in Payments
- APRETUDE (Biological) $247.17
- VAXNEUVANCE (Biological) $144.38
- ZERBAXA (Drug) $100.00
- DOVATO (Drug) $77.70
- BD Nano 2nd Gen Pen Needle (Device) $62.70
- CABENUVA (Biological) $60.79
- TEFLARO (Drug) $27.39
- VIBATIV (Drug) $24.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.